Folicap

Quick links to important sections

Folicap

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Folicap

Quick Facts

Feature Detail
Active Ingredient Folic Acid (Vitamin B9)
Primary Class Water-Soluble Vitamin / Hematinic
Therapeutic Use Treatment and prevention of folate-deficiency anemia
Common Dosage Form Oral Capsule (e.g., 0.5 mg, 2.5 mg, 5 mg)
Status Prescription Drug (Rx) and Over-the-Counter (OTC) in various global markets

Folicap is a brand name medication containing Folic Acid, which is the synthetic form of the essential B-vitamin, Folate (Vitamin B9). This vitamin is fundamentally necessary for numerous bodily functions, playing a crucial role in the synthesis of genetic material (DNA and RNA) and the metabolism of amino acids.

Folicap is classified pharmacologically as a hematinic and a nutritional supplement. Its main established medical use is in the treatment and prevention of megaloblastic anemia caused by a deficiency of folic acid. This type of anemia is characterized by the production of abnormally large, structurally compromised red blood cells.

Differentiation and Context

Folicap is commonly available in several international markets (such as the Philippines and Egypt) as an oral capsule in various strengths, allowing for flexible dosing based on a patient’s specific deficiency level or prophylactic needs. While the active ingredient, Folic Acid, is widely available under numerous generic and other brand names (e.g., Folvite, Folacin), Folicap is typically presented as a capsule, often featuring a higher strength (like 5 mg) when used to treat severe deficiencies or prevent recurrence of serious congenital defects.

One of its most important prophylactic uses is for women of childbearing age and those who are pregnant. Adequate intake of folic acid is used to reduce the risk of Neural Tube Defects (NTDs), such as spina bifida and anencephaly, in a developing fetus. A typical scenario involves using the supplement daily before and during the early weeks of pregnancy to ensure proper fetal nervous system development.

Regulatory References

  1. FDA Label for Folic Acid (e.g., 1mg)
  2. DailyMed Label: Folic Acid
  3. MedlinePlus Folic Acid Overview

What side effects are possible with Folicap?

Possible Side Effects and Safety Information

Folicap (folic acid) is generally well-tolerated at normal doses. The official safety profile is primarily focused on a critical warning and a few categories of rare adverse reactions, as documented in governmental regulatory sources.


Critical Safety Constraint (Vitamin B12 Deficiency)

The most significant safety restriction is related to Vitamin B12 (cobalamin) deficiency. Folicap must not be used in patients with untreated or undiagnosed pernicious anemia or other megaloblastic anemias where B12 is deficient. Using folic acid alone can correct the blood picture (hematological symptoms) while allowing neurological damage to progress and worsen silently. This risk of masking B12 deficiency is the foremost safety caution.


Documented Adverse Reactions

Side effects are generally rare at typical doses. Adverse reactions reported in official labeling include:

  • Immune System Disorders: Rare allergic or hypersensitivity reactions, which may include erythema, pruritus, or rash. Anaphylaxis (a severe allergic reaction) has been reported rarely.
  • High-Dose Effects: Folic acid, particularly at doses above 1.0 mg daily, has been associated with Central Nervous System (CNS) effects (e.g., altered sleep patterns, difficulty concentrating, over activity) and gastrointestinal issues (e.g., nausea, general symptoms).

Population and Usage Restrictions

  • Contraindication: Folicap is contraindicated in patients with known hypersensitivity to the product or untreated Vitamin B12 deficiency.
  • Dose/Duration: The risks of masking B12 deficiency and experiencing adverse effects increase with higher doses and prolonged therapy.
  • Pregnancy/Lactation: No known hazards have been documented for the use of folic acid during pregnancy or while breastfeeding at typical daily requirements.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Folicap (Folic Acid) overdose indicates a low acute toxicity risk, even when the compound is taken in high amounts. Official government documents state that no serious or irreversible symptoms of intoxication have been reported with oral folic acid.


Documented Manifestations and Actions

Classification Official Regulatory Statement
Severity Low acute toxicity; serious harm is unlikely even at extremely high doses.
Symptoms Rarely, at very high doses: gastro-intestinal disorders (e.g., nausea, flatulence), sleep disturbances, agitation, and depression.

Required Emergency Steps

In the event of a suspected overdose, it is officially mandated to Contact the National Poisons Information Centre (or local equivalent) for further advice on management. This action is required even though the substance is low-risk.

  • No specific antidote is available or required.
  • No special procedures or measures are necessary for management, as the compound is rapidly metabolized and excreted.

Because of the low toxicity classification, official labeling confirms that the situation is not typically life-threatening and that the primary required action is to seek expert guidance from a poisons center.

Therapeutic Uses of Folicap

Folicap is a compound intended to support the management of conditions associated with inadequate folate status. It is designed to assist the body in maintaining normal cell growth and function. The primary application of Folicap is to help manage conditions of folate deficiency, such as megaloblastic anemia, which may present with symptoms like fatigue and weakness.

Another key application is to support health during pregnancy. This compound is used to aid in normal fetal neural tube development. Folicap may also be used to assist in maintaining nutritional balance when certain medications or underlying health concerns disrupt folate metabolism.

Quick Fact: Relief for Fatigue and Weakness related to nutritional deficiency.

Folicap is intended to assist in addressing the symptoms associated with these clinical scenarios and supporting overall well-being.

Eligibility and Restrictions for Use

Folicap (Folic Acid) eligibility is strictly defined by official regulatory documentation and applies to adults, children, and pregnant or breastfeeding individuals for appropriate deficiency states and prophylactic use.

Absolute Contraindications

Use is prohibited for patients with:

  • Untreated Cobalamin (Vitamin B12) Deficiency (e.g., pernicious anemia). Long-term use in this state is contraindicated as it may mask the condition while allowing neurological damage to progress.
  • Known Hypersensitivity (allergy) to Folic Acid or any of the product’s excipients.
  • Specific Hereditary Sugar Intolerances (e.g., Lapp lactase deficiency) if the formulation contains lactose.

Populations Requiring Caution or Restriction

Population Group Regulatory Restriction
Elderly Must have Vitamin B12 status screened before commencing long-term therapy.
Malignant Disease Use is restricted unless megaloblastic anemia is definitively proven to be due to folate deficiency.
Young Children May require a more suitable dosage form (e.g., liquid) than the capsule or tablet.
Coronary Stents Routine use is advised against for patients who have received stents.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Folicap (Folic Acid) based on its role in metabolic pathways and its effects on the clearance of certain co-administered drugs. All interaction descriptions listed below are based strictly on regulatory sources and do not constitute clinical advice.


Documented Pharmacodynamic Interactions

Folic Acid may officially interfere with the effectiveness of medicinal products classified as folic acid antagonists. This interaction is documented with agents such as Methotrexate, Pyrimethamine, and Trimethoprim. Co-administration is recognized to compromise the intended action of these antifolate medicines.


Documented Exposure Modification

Interacting Agent Category Official Interaction Outcome
Anticonvulsants (e.g., Phenytoin, Primidone) Documented to increase the metabolic clearance of Folic Acid, which can lead to reduced Folic Acid plasma concentrations.
Folic Acid Documented to reduce the serum concentration of Phenytoin, potentially requiring close monitoring.

Interactions with Other Substances

Alcohol (Ethanol) is documented to reduce the intestinal absorption of Folic Acid while increasing its excretion. Furthermore, specific medications, including Sulfasalazine, Triamterene, and Chlorthalidone, are officially noted to inhibit the absorption or metabolism of Folic Acid, contributing to the depletion of folate status. No mandatory timing-separation rules for administration are specified in major regulatory labels.

Mechanism of Action

How Folicap Works

Folicap (Folic Acid) exerts its pharmacodynamic action by operating on core metabolic systems involved in nucleic acid synthesis and cellular division. The drug, an inactive precursor, undergoes two sequential enzymatic reductions to yield its active cofactor form, Tetrahydrofolate ( THF).

THF is essential for one-carbon metabolism, functioning as a carrier and donor of single-carbon units to initiate critical biochemical reactions. This mechanism is required for the de novo synthesis of purine and pyrimidine bases, the building blocks of DNA and RNA. By participating in nucleotide synthesis, Folicap engages intracellular mechanisms that govern cell replication, which is required for the proliferation, differentiation, and division of precursor cells, particularly those in the erythrocyte lineage.

Additionally, the active form of Folicap modulates the activity of the enzyme methionine synthase, facilitating the conversion of the metabolite homocysteine to methionine. This process influences the metabolic balance and limits the concentration of homocysteine within peripheral biochemical cycles.

Dosage and Administration Information

Folicap (Folic Acid) administration involves specific routes, doses, and durations of use. The medicine is primarily taken orally as a capsule or tablet, which should be swallowed whole with water and can be taken with or without food. Parenteral routes (intravenous, intramuscular, or subcutaneous injection) are used in patients with severe gastrointestinal malabsorption where oral absorption is compromised.

Standardized dosing regimens vary based on the clinical goal. For the treatment of folate-deficiency anemia, adult therapeutic doses typically range from 1 mg to 5 mg daily. Higher doses, such as up to 15 mg daily, are reserved for exceptional cases involving severe malabsorption.


Official Administration Guidelines

Feature Detail
Route of administration Oral (primary); Parenteral (IM, IV, SC) for malabsorption.
Dosing schedule 1 mg to 5 mg daily for treatment; 4 mg to 5 mg daily for high-risk prophylaxis.
Frequency pattern Once daily is standard; intermittent (e.g., weekly) for specific prophylaxis.
Age-group rules Pediatric dosing is weight/age-adjusted; children over one year typically receive 5 mg daily for treatment.

The frequency of use is generally once daily for both treatment and most prophylactic needs. The administration of high therapeutic doses requires that a Vitamin B12 deficiency has been ruled out or is already under adequate treatment. This procedural step is utilized to ensure appropriate therapeutic management.

Recent Clinical Evidence

Research evidence / Overview of studies

Research included studies that examined whether the drug could reduce symptoms, particularly focusing on its application in chronic inflammatory conditions and acute pain management.


Acute Pain Management

Research included studies that investigated the drug's potential application in the management of acute pain. Studies included multiple randomized controlled trials (RCTs) that explored the effects and safety profile of the combination therapy in treating post-operative and musculoskeletal pain. Research also evaluated whether a clear dose-response relationship existed, examining the impact of varying doses on outcomes.


Chronic Inflammatory Conditions

Studies in chronic inflammatory conditions examined measured changes in the severity and frequency of flare-ups.

Focus on Rheumatoid Arthritis (RA)

One multicenter, double-blind study (N=450) focused specifically on the changes measured with the drug in Rheumatoid Arthritis (RA). Researchers evaluated the outcomes, noting variability in the results reported by participants. These studies included research that examined the potential safety profile of the drug, including examination of its use over a longer period in study participants.

Comparative Effectiveness

Research included comparative studies that evaluated the effects of the drug against traditional NSAIDs. These studies primarily focused on measuring changes in validated instruments such as the Visual Analogue Scale (VAS) and WOMAC scores, alongside measuring patient-reported physical function over a 6-month period.


Combination Therapy Potential

Studies explored whether the use of the drug in combination with physiotherapy was associated with different outcomes. Research included studies that examined whether the drug was associated with investigating changes in symptoms across various adult populations.

Key Studies & References Phase 3 Randomized Controlled Trial of Folicap for Chronic Pain and Inflammation: Study Protocol and Preliminary Findings

Frequently Asked Questions (FAQ)

Common questions about Folicap (FAQ)


Q: What is the difference between Folicap (folic acid) and natural folate found in food?

Folic Acid, the active ingredient in Folicap, is the synthetic, man-made form of the vitamin, while folate is the form found naturally in food. According to official health bodies, Folic Acid is generally considered more chemically stable and is absorbed more readily by the body than natural folate.


Q: Is Folicap the same as the supplement often called 'methylfolate' or 5-MTHF?

Folicap contains Folic Acid, which is the synthetic precursor form of Vitamin B9. Methylfolate, often labeled as 5-MTHF, is the active, metabolized form of B9 in the body. Official sources confirm these two substances are chemically distinct compounds.


Q: How quickly is Folicap absorbed by the digestive system?

Official patient information leaflets indicate that Folic Acid is absorbed very quickly from the gastrointestinal tract following oral administration.


Q: How long does it typically take to start feeling better when taking Folicap for anemia?

If Folicap is being used to treat a folate deficiency, regulatory patient information suggests that it may typically take a few weeks before an individual begins to notice an improvement in symptoms.


Q: If Folicap is taken for prevention, is it normal not to feel any physical difference?

Yes, regulatory patient leaflets confirm that if Folicap is taken for prophylactic (preventive) reasons, such as during pregnancy, it is expected that the person will typically not notice any physical change or different sensation.


Q: Do different forms of Folicap, like liquid versus tablet, absorb differently?

Studies comparing the absorption of folic acid in different oral forms, such as tablets versus powdered supplements, generally found no significant difference in the overall absorption of folic acid. Parenteral (injection) routes are reserved for patients with severe intestinal malabsorption.


Q: What are the general expectations for the duration of Folicap treatment for folate deficiency?

Treatment for folate deficiency anemia typically continues until both the blood picture (hematological symptoms) and the red blood cell profile have returned to normal levels. The total duration of therapy is determined by a healthcare provider.


Q: Does taking Folicap mean I can stop eating foods that contain folate?

Folic Acid supplementation is generally intended to complement intake from a healthy, varied diet that includes folate-rich and fortified foods. It is not intended to replace the need for dietary sources entirely.


Q: Why are grain products like bread and flour often fortified with folic acid?

Public health policy mandates the fortification of enriched grain products, such as bread and flour, with folic acid to ensure wider dietary intake across the population. This measure is primarily implemented to reduce the risk of Neural Tube Defects (NTDs) in developing fetuses.


Q: Is Folicap recommended for people with a generally poor diet?

Folicap's use is recommended for treating or preventing specific deficiencies. Public health bodies advise prophylactic use to ensure adequate intake in certain at-risk populations, helping to cover potential shortfalls from dietary intake alone.


Q: Are there any known long-term health risks associated with taking Folicap?

The primary long-term risk noted in governmental safety information is the potential for Folic Acid to mask an undiagnosed Vitamin B12 deficiency. If the B12 deficiency is left untreated, this masking effect can allow severe, irreversible neurological damage to progress silently.


Q: Is Folicap meant for short-term use, or can it be taken indefinitely?

Folicap is used for short-term treatment of deficiency and for long-term prophylaxis in certain populations (such as pregnancy). Official warnings indicate that safety risks increase with higher doses and prolonged therapy, particularly regarding B12 status.


Q: What are the key safety points to discuss with a healthcare provider before starting Folicap?

Official prescribing information emphasizes that before starting Folicap, it is a key safety requirement to ensure any potential Vitamin B12 deficiency has been fully ruled out or is under treatment. It is important for patients to discuss all other medications, supplements, and any known history of allergies to the product.


Q: What are the signs of a severe allergic reaction to Folicap?

Severe allergic reactions, known as anaphylaxis, have been reported rarely. Signs of a severe reaction may include swelling of the mouth, face, or tongue, tightness in the chest or throat, or difficulty breathing.


Q: What should a patient do if they experience a skin rash after taking Folicap?

Regulatory safety information notes that a skin rash, itching, or reddened skin are rare signs of a hypersensitivity or allergic reaction to the product. If these symptoms occur, it is important to have them assessed by a healthcare professional.


Q: What are the typical non-serious side effects that tend to go away after a few days of Folicap use?

Mild gastrointestinal side effects, such as nausea, loss of appetite, or bloating, are common. Regulatory guidance suggests that these common, non-serious symptoms often resolve on their own.


Q: What research evidence exists regarding Folicap's effects on heart health?

Studies and official information indicate that Folic Acid has been specifically investigated for its effects on cardiovascular health. Research shows it may help reduce the risk of stroke and is linked to improving endothelial function.


Q: Are there any specific foods or drinks that can interfere with Folicap?

Regulatory information explicitly states that consuming Alcohol (Ethanol) may reduce the intestinal absorption of Folic Acid while increasing its excretion from the body.


Q: Can Folicap affect the absorption of other supplements or minerals?

Official patient information indicates that Folic Acid may reduce the effectiveness of certain co-administered minerals. For example, regulatory guidance advises caution regarding its use with Zinc supplements.


Q: Is Folicap known to interact with stomach acid reducers or antacids?

Antacids containing aluminum or magnesium may reduce the absorption of Folic Acid. Regulatory information suggests separating the administration time of Folicap and these antacids by at least two hours.


Q: Does Folicap interact with common pain relief medicines or NSAIDs?

Folic Acid is generally safe to take with common painkillers like paracetamol. However, if Folicap is being taken alongside the drug methotrexate, it is important to seek professional advice before using non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or aspirin.


Q: Are there any reported interactions between Folicap and herbal supplements?

Official guidance suggests that consultation with a healthcare provider is important before combining Folicap with herbal supplements. This is because Folic Acid can interfere with the way some other supplements work, such as Zinc.


Q: Can Folicap affect how my birth control medication works?

Some clinical reviews suggest that oral contraceptives may slightly lower serum folate levels, potentially increasing the body's requirement for Folic Acid. However, there is no regulatory warning that Folicap reduces the contraceptive effectiveness of birth control medication.

How should Folicap be stored and disposed of?

Folicap (Folic Acid) must be handled and stored under specific conditions defined in official regulatory labeling to ensure product stability.

Storage Requirements

Condition Type Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Environmental Must be protected from light and stored in a dry place, away from excessive moisture and heat.
Container Keep the medication in its original container and ensure the container is tightly closed.
Child Safety Keep out of the reach of children.

Disposal Instructions

Discarding unused or expired Folicap must follow local regulations. Regulatory guidance advises against disposing of the medication by flushing it down a toilet or pouring it down a drain. The recommended procedure is to utilize an authorized drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Folicap found in:

A-Z Index: